NASDAQ : PRCT
PROCEPT BioRobotics Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 19.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.10B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.12B |
| Enterprise Value | 973.30M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 57.27M |
| Shares Outstanding | 57.27M |
| Shares Change (YoY) | +4.24% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 2.56% |
| Owned by Institutions (%) | 95.60% |
| Float | 55.81M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.26 |
| Forward PS | 2.51 |
| PB Ratio | 3.23 |
| P/TBV Ratio | 3.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.55 |
| Quick Ratio | 5.23 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.73 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -30.24% |
| Return on Assets (ROA) | -14.75% |
| Return on Invested Capital (ROIC) | -16.59% |
| Return on Capital Employed (ROCE) | -28.21% |
| Weighted Average Cost of Capital (WACC) | 8.92% |
| Revenue Per Employee | $379,889 |
| Profits Per Employee | -$123,598 |
| Employee Count | 888 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.72 |
Taxes
| Measure | Value |
|---|
| Income Tax | 152,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -43.29% |
| 50-Day Moving Average | 19.35 |
| 200-Day Moving Average | 23.27 |
| Relative Strength Index (RSI) | 51.39 |
| Average Volume (20 Days) | 1,054,144 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.50M |
| Short Previous Month | 7.43M |
| Short % of Shares Out | 13.10% |
| Short % of Float | 13.44% |
| Short Ratio (days to cover) | 5.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 337.34M |
| Gross Profit | 213.75M |
| Operating Income | -117.13M |
| Pretax Income | -109.60M |
| Net Income | -109.76M |
| EBITDA | -110.08M |
| EBIT | -117.13M |
| Loss Per Share | -$1.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 227.91M |
| Total Debt | 77.50M |
| Net Cash | 150.41M |
| Net Cash Per Share | $2.63 |
| Equity (Book Value) | 340.07M |
| Book Value Per Share | 5.94 |
| Working Capital | 356.09M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -74.34M |
| Capital Expenditures | -10.59M |
| Depreciation & Amortization | 7.05M |
| Net Borrowing | n/a |
| Free Cash Flow | -84.93M |
| FCF Per Share | -$1.48 |
Margins
| Measure | Value |
|---|
| Gross Margin | 63.36% |
| Operating Margin | -34.72% |
| Pretax Margin | -32.49% |
| Profit Margin | -32.54% |
| EBITDA Margin | -32.63% |
| EBIT Margin | -34.72% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.24% |
| Shareholder Yield | -4.24% |
| Earnings Yield | -9.93% |
| FCF Yield | -7.72% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $22.25 |
| Price Target Difference | 13.41% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 22.18% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 6.73 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |